Trevi Therapeutics (TRVI) Q4 2024 Earnings

6NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.13
-0.11
-0.1
-0.08

Details

Expected EPS
-0.11954
Actual EPS
-0.13
Surprise EPS
-0.01
Surprise Percent
+8.75%

Description

Trevi Therapeutics (TRVI) has reported earnings of -0.13 per share for Q4 2024.

0 Comments

Share your thoughts